HOME › DRUGS › CERTOLIZUMAB PEGOL
ACTIVE SUBSTANCE / INN

CERTOLIZUMAB PEGOL

Brand name(s): CIMZIA, Cimzia
FDA LISTED
EMA LISTED
PRESCRIPTION
REFUSED
AUTHORISED
BLA125160
Arthritis, Rheumatoid
ACTIVE SUBSTANCE
Certolizumab Pegol
REGULATORS
FDA · EMA
SPONSORS / MAH
UCB INC, UCB Pharma SA, UCB Pharma
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CIMZIABLA125160UCB INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CimziaUCB PharmaAuthorised01/10/2009Arthritis, Rheumatoid
CimziaUCB Pharma SARefusedCrohn Disease

FULL INTELLIGENCE ON CERTOLIZUMAB PEGOL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →